Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in CashChange in InventoryChange in InventoryDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based CompensationShort-Term Debt repayments
Growth Metrics
Income Statement
Others
Ratios

Medicure (MCUJF) Net Cash Flow (2016 - 2025)

Medicure has reported Net Cash Flow over the past 16 years, most recently at $40156.8 for Q4 2025.

  • For Q4 2025, Net Cash Flow fell 96.78% year-over-year to $40156.8; the TTM value through Dec 2025 reached -$2.2 million, down 1427.97%, while the annual FY2025 figure was -$2.2 million, 1227.69% down from the prior year.
  • Net Cash Flow for Q4 2025 was $40156.8 at Medicure, up from -$451240.3 in the prior quarter.
  • Over five years, Net Cash Flow peaked at $1.6 million in Q2 2022 and troughed at -$1.8 million in Q2 2025.
  • A 5-year average of -$4261.8 and a median of -$19205.5 in 2023 define the central range for Net Cash Flow.
  • Biggest five-year swings in Net Cash Flow: skyrocketed 226.28% in 2021 and later crashed 991.54% in 2025.
  • Year by year, Net Cash Flow stood at $310987.7 in 2021, then fell by 23.72% to $237218.3 in 2022, then soared by 125.11% to $534007.3 in 2023, then skyrocketed by 133.39% to $1.2 million in 2024, then plummeted by 96.78% to $40156.8 in 2025.
  • Business Quant data shows Net Cash Flow for MCUJF at $40156.8 in Q4 2025, -$451240.3 in Q3 2025, and -$1.8 million in Q2 2025.